EC Healthcare (HKG:2138)
Hong Kong · Delayed Price · Currency is HKD 0.6200
0.00 (0.00%)
At close: Feb 13, 2026
EC Healthcare Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 4,008 | 4,140 | 4,211 | 3,875 | 2,920 | 2,080 |
| 4,008 | 4,140 | 4,211 | 3,875 | 2,920 | 2,080 | |
Revenue Growth (YoY) | -3.48% | -1.68% | 8.66% | 32.74% | 40.33% | 6.77% |
Cost of Revenue | 2,842 | 2,890 | 2,881 | 2,614 | 1,734 | 1,264 |
Gross Profit | 1,166 | 1,250 | 1,330 | 1,261 | 1,185 | 816.04 |
Selling, General & Admin | 586.11 | 595.91 | 599.48 | 560.33 | 426.8 | 322.2 |
Amortization of Goodwill & Intangibles | 109.02 | 118.18 | 108.92 | 97.77 | 71.38 | 31.97 |
Other Operating Expenses | -4.26 | -4.69 | -4.32 | -4.71 | -5.42 | -5.15 |
Operating Expenses | 1,183 | 1,222 | 1,221 | 1,142 | 853.75 | 626.91 |
Operating Income | -16.67 | 27.72 | 109.58 | 119.04 | 331.67 | 189.13 |
Interest Expense | -80.44 | -90.7 | -100.84 | -63.64 | -48.91 | -23.65 |
Interest & Investment Income | 18.48 | 17.63 | 17.22 | 4.87 | 1.36 | 1.71 |
Earnings From Equity Investments | -97.73 | -95.43 | 5.43 | 12.33 | -0.67 | 4.99 |
Other Non Operating Income (Expenses) | -19.65 | -16.08 | 36.93 | 32.72 | 18.54 | 8.27 |
EBT Excluding Unusual Items | -196.01 | -156.86 | 68.32 | 105.33 | 301.99 | 180.45 |
Merger & Restructuring Charges | -0.46 | -0.46 | -0.48 | -0.28 | -1.21 | -1.02 |
Impairment of Goodwill | -115.6 | -115.6 | - | -7.48 | - | - |
Gain (Loss) on Sale of Investments | -26.48 | -26.75 | -24.58 | -19.09 | -11.57 | -2.89 |
Gain (Loss) on Sale of Assets | 263.49 | 266.92 | -1.84 | 3.64 | 19.12 | 16.78 |
Asset Writedown | -68.69 | -68.69 | -26.38 | 2.2 | 10.8 | -2.7 |
Other Unusual Items | 0.3 | 0.3 | 1.83 | 51.88 | 2.28 | 75.28 |
Pretax Income | -143.45 | -101.14 | 16.87 | 136.19 | 321.41 | 265.9 |
Income Tax Expense | 4.55 | 10.78 | 1.18 | 29.16 | 50.91 | 40.3 |
Earnings From Continuing Operations | -148 | -111.92 | 15.7 | 107.03 | 270.5 | 225.59 |
Minority Interest in Earnings | -43.59 | -55.27 | -34.64 | -37.37 | -73 | -32.73 |
Net Income | -191.6 | -167.19 | -18.95 | 69.65 | 197.5 | 192.87 |
Net Income to Common | -191.6 | -167.19 | -18.95 | 69.65 | 197.5 | 192.87 |
Net Income Growth | - | - | - | -64.73% | 2.40% | -32.70% |
Shares Outstanding (Basic) | 1,185 | 1,185 | 1,185 | 1,181 | 1,153 | 1,027 |
Shares Outstanding (Diluted) | 1,185 | 1,185 | 1,185 | 1,184 | 1,173 | 1,031 |
Shares Change (YoY) | - | - | 0.08% | 0.94% | 13.79% | 4.33% |
EPS (Basic) | -0.16 | -0.14 | -0.02 | 0.06 | 0.17 | 0.19 |
EPS (Diluted) | -0.16 | -0.14 | -0.02 | 0.06 | 0.17 | 0.19 |
EPS Growth | - | - | - | -64.88% | -10.16% | -35.52% |
Free Cash Flow | 550.19 | 686.07 | 527.88 | 194.27 | 348.09 | 484.94 |
Free Cash Flow Per Share | 0.46 | 0.58 | 0.45 | 0.16 | 0.30 | 0.47 |
Dividend Per Share | - | 0.010 | 0.005 | 0.100 | 0.144 | 0.159 |
Dividend Growth | - | 100.00% | -95.00% | -30.56% | -9.43% | -30.87% |
Gross Margin | 29.09% | 30.19% | 31.59% | 32.55% | 40.60% | 39.23% |
Operating Margin | -0.42% | 0.67% | 2.60% | 3.07% | 11.36% | 9.09% |
Profit Margin | -4.78% | -4.04% | -0.45% | 1.80% | 6.77% | 9.27% |
Free Cash Flow Margin | 13.73% | 16.57% | 12.54% | 5.01% | 11.92% | 23.31% |
EBITDA | 294.35 | 361.56 | 392.44 | 352.13 | 497.07 | 304.37 |
EBITDA Margin | 7.34% | 8.73% | 9.32% | 9.09% | 17.03% | 14.63% |
D&A For EBITDA | 311.02 | 333.83 | 282.86 | 233.08 | 165.41 | 115.23 |
EBIT | -16.67 | 27.72 | 109.58 | 119.04 | 331.67 | 189.13 |
EBIT Margin | -0.42% | 0.67% | 2.60% | 3.07% | 11.36% | 9.09% |
Effective Tax Rate | - | - | 6.99% | 21.41% | 15.84% | 15.16% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.